Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

31.84
Delayed Data
As of 3:59pm ET
 +0.29 / +0.92%
Today’s Change
20.39
Today|||52-Week Range
35.06
-3.57%
Year-to-Date

Today’s Trading

Previous close31.55
Today’s open31.99
Day’s range31.61 - 32.42
Volume164,110
Average volume (3 months)239,355
Market cap$600.6M
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-72.37%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-45.13%
P/E ratio21.1
Price/Sales5.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.13+2.29%
HRTXHeron Therapeutics I...+0.55+3.58%
CLLSCellectis SA+0.22+1.29%
PGNXProgenics Pharmaceut...+0.22+2.55%
Data as of 3:59pm ET, 12/05/2016

Financials

Next reporting dateFebruary 6, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$88.3M
Annual profit (last year)$21.7M
Net profit margin24.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Jay R. Luly
CFO, Senior VP-Finance &
Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts


Search for Jobs